REPLAGAL

Google image searchProduct monograph

Active ingredient

agalsidase alfa, 1 MG/ML

DIN: 02249057

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: TAKEDA CANADA INC

Date: 13-OCT-2021

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB03 — AGALSIDASE ALFA (ATC/DDD)

Reference brand drug: Replagal

External Links for Replagal

Search on Google

• Replagal side effects
• Replagal dosage
• agalsidase alfa side effects
• agalsidase alfa dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find replagal photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.